Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3053% above fair value
$28.47−0.39 (-1.35%)
Close on Nov 17, 2026Market cap $162.27BP/E 37.5Yield 6.04%
Pfizer price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Pfizer's price to book ratio was 2.0× on Nov 10, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 1.5× to 4.4×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 2.0× | +0.4 |
| 2025 | Dec 31, 2025 | 1.5× | −0.1 |
| 2024 | Dec 31, 2024 | 1.6× | −0.1 |
| 2023 | Dec 29, 2023 | 1.7× | −1.5 |
| 2022 | Dec 30, 2022 | 3.2× | −1.3 |
| 2021 | Dec 31, 2021 | 4.4× | +1.3 |
| 2020 | Dec 31, 2020 | 3.2× | −0.3 |
| 2019 | Dec 31, 2019 | 3.5× | −0.2 |
| 2018 | Dec 31, 2018 | 3.7× | +0.1 |
| 2017 | Dec 29, 2017 | 3.6× | +0.4 |
| 2016 | Dec 30, 2016 | 3.2× | +0.1 |
| 2015 | Dec 31, 2015 | 3.0× | +0.5 |
| 2014 | Dec 31, 2014 | 2.6× | −0.2 |
| 2013 | Dec 31, 2013 | 2.8× | +0.5 |
| 2012 | Dec 31, 2012 | 2.3× | +0.4 |
| 2011 | Dec 30, 2011 | 1.9× | +0.3 |
| 2010 | Dec 31, 2010 | 1.6× | −0.3 |
| 2009 | Dec 31, 2009 | 1.9× | – |
See a number that looks wrong?